North China Pharmaceutical Company Ltd. (600812.SS)
CNY 5.49
(-0.54%)
CNY 5.49
(-0.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.02 Billion | 1 Billion | 1.05 Billion | 752.14 Million | 732.96 Million | 774.32 Million |
| Net Income | 4.89 Million | -678.78 Million | 35.38 Million | 104.47 Million | 147.9 Million | 145.81 Million |
| Depreciation & Amortization | 888.83 Million | 779.02 Million | 703.23 Million | 620.11 Million | 569.94 Million | 545.59 Million |
| Deferred income taxes | -1.84 Million | -5.23 Million | -1.47 Million | -579.05 Thousand | -1.31 Million | -484.03 Thousand |
| Stock-based compensation | -2.15 Billion | 5.23 Million | 1.47 Million | 579.05 Thousand | 1.31 Million | - |
| Change in working capital | -381.54 Million | -500.29 Million | -302.31 Million | -593.74 Million | -519.15 Million | -404.84 Million |
| Other non-cash items | 2.67 Billion | 1.4 Billion | 613.94 Million | 621.29 Million | 534.27 Million | 487.75 Million |
| Investing Cash Flow | -882.34 Million | -528.46 Million | -779.26 Million | -843.57 Million | -560.57 Million | -468.98 Million |
| Investments in PPE | -623.03 Million | -549.58 Million | -547.49 Million | -1 Billion | -645.96 Million | -506.63 Million |
| Acquisitions | 690.94 Thousand | 22.25 Million | 6.54 Million | 141.81 Million | 66.22 Million | 4.16 Million |
| Investment purchases | -260 Million | -2 Million | -240 Million | -141.81 Million | -66.22 Million | - |
| Sales/Maturities of investments | 589.47 Thousand | 860.71 Thousand | 1.68 Million | 21.43 Million | 19.16 Million | 33.49 Million |
| Other Investing Activities | -589.47 Thousand | 1.24 | 0.27 | 141.81 Million | 66.22 Million | 4.16 Million |
| Financing Cash Flow | -704.14 Million | -4.47 Billion | 314.57 Million | 3.43 Billion | -141.94 Million | -207.08 Million |
| Debt repayment | -247.8 Million | -13.22 Billion | -9.54 Billion | -11.51 Billion | -10.72 Billion | -7.98 Billion |
| Dividends payments | -516.22 Million | -102.94 Million | -48.93 Million | -48.92 Million | -48.92 Million | -520.21 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -628.08 Million | 9.49 Billion | 10.6 Billion | 15.6 Billion | 11.18 Billion | 8.3 Billion |
| Accounts receivables | 342.82 Million | -578.35 Million | -329.24 Million | -137.83 Million | -394.55 Million | 56.42 Million |
| Accounts payables | -637.26 Million | 275.22 Million | -58.2 Million | -207.64 Million | -147.86 Million | -66.32 Million |
| Inventory | -87.1 Million | -191.92 Million | 86.6 Million | -247.67 Million | -19.5 Million | -394.46 Million |
| Other working capital | -639.11 Million | -5.23 Million | -1.47 Million | -579.06 Thousand | 42.75 Million | -10.38 Million |
| Cash at beginning of period | 1.68 Billion | 5.04 Billion | 4.46 Billion | 1.13 Billion | 994.06 Million | 895.44 Million |
| Cash at end of period | 988.27 Million | 1.05 Billion | 5.04 Billion | 4.46 Billion | 1.02 Billion | 994.06 Million |
| Capital Expenditure | -623.03 Million | -549.58 Million | -547.49 Million | -1 Billion | -645.96 Million | -506.63 Million |
| Effect of forex changes on cash | 12.06 Million | 8.43 Million | -3.13 Million | -11.14 Million | 3.11 Million | 351.35 Thousand |
| Net cash flow / Change in cash | -694.46 Million | -3.99 Billion | 582.41 Million | 3.33 Billion | 33.56 Million | 98.61 Million |
| Free Cash Flow | 401.82 Million | 454.8 Million | 502.74 Million | -254.67 Million | 86.99 Million | 267.68 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 30.47 Million | 53.83 Million | 18.15 Million | -23.08 Million | 4.89 Million | 1.42 Million |
| Depreciation & Amortization | - | 212.79 Million | 212.79 Million | 249.53 Million | 888.83 Million | -382.81 Million |
| Deferred income taxes | - | - | - | - | -1.84 Million | - |
| Stock-based compensation | - | - | - | - | -2.15 Billion | - |
| Change in working capital | - | 117.3 Million | - | 255.71 Million | -381.54 Million | 383.29 Million |
| Other non-cash items | 144.73 Million | 475.05 Million | 548.93 Million | 204.09 Million | 2.67 Billion | 326.83 Million |
| Investing Cash Flow | -153.19 Million | -809 Million | -192.68 Million | -452.9 Million | -882.34 Million | -171.74 Million |
| Investments in PPE | -153.19 Million | -135.99 Million | -192.68 Million | -242.9 Million | -623.03 Million | -122.65 Million |
| Acquisitions | 674.26 Million | -673 Million | - | - | 690.94 Thousand | 317.54 Thousand |
| Investment purchases | - | - | - | -210 Million | -260 Million | -50 Million |
| Sales/Maturities of investments | - | - | - | - | 589.47 Thousand | 49.68 Million |
| Other Investing Activities | - | 1.25 Million | - | -210 Million | -589.47 Thousand | -49.09 Million |
| Financing Cash Flow | -76.8 Million | 1.51 Billion | -489.39 Million | -398.91 Million | -704.14 Million | -238.07 Million |
| Debt repayment | -76.12 Million | -408.68 Million | -71.6 Million | -180.73 Million | -247.8 Million | -2.55 Billion |
| Dividends payments | -129.91 Million | -121.17 Million | -118.5 Million | -148.75 Million | -516.22 Million | -88.23 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -23.01 Million | 1.12 Billion | -417.78 Million | 105.68 Million | -628.08 Million | 2.41 Billion |
| Accounts receivables | - | 75.98 Million | - | 342.82 Million | 342.82 Million | 389.14 Million |
| Accounts payables | - | - | - | - | -637.26 Million | - |
| Inventory | - | 41.31 Million | - | -87.1 Million | -87.1 Million | -5.85 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.42 Billion | 869.69 Million | 988.27 Million | 1.48 Billion | 1.68 Billion | 1 Billion |
| Cash at end of period | 1.37 Billion | 1.77 Billion | 869.69 Million | 988.27 Million | 988.27 Million | 923.38 Million |
| Capital Expenditure | -153.19 Million | -135.99 Million | -192.68 Million | -242.9 Million | -623.03 Million | -122.65 Million |
| Effect of forex changes on cash | -594.71 Thousand | 6.18 Million | 2.47 Million | 2.89 Million | 12.06 Million | 1.66 Million |
| Net cash flow / Change in cash | -55.37 Million | 900.44 Million | -118.57 Million | -495.98 Million | -694.46 Million | -79.41 Million |
| Free Cash Flow | 22.01 Million | 180.1 Million | 374.4 Million | 187.63 Million | 401.82 Million | 206.08 Million |
AACTF
PII
GSMGW
TXG
5264
STRINV